Aurobindo Pharma previously took support from support zone and 200 EMA (blue line).
FII increased their stake during the 2nd quarter as well.
Accumulate with a SL of 318 WCLBS.
Final target new ATH
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.